
Conference Coverage
Latest Content

Importance of Monitoring Patients’ Hormonal Contraceptive Use

The Psychiatrist’s Preview of Legal Cases Against Big AI

New AAN Poster Presentation on Alixorexton for Narcolepsy Type 1: Improvement in Disease Severity, Cognitive Functioning, and Fatigue

Ongoing Trial for PBFT02 Shows Improvement of Frontotemporal Dementia With Granulin Mutations

Empathetic Curiosity: Better Engaging Youth With Substance Use Disorder

Shorts










Digital Edition
Podcasts
Continuing Medical Education
All News

Learn more about how sex hormones and prolactin shape brain circuits, revealing new biomarkers and treatment strategies for eating disorders, psychosis, and depression.

Learn more about the treatment of depression, selective serotonin reuptake inhibitors, and pregnancy in this podcast.

New evidence shows lithium adds minimal weight in bipolar disorder and explains why some gain occurs—plus practical tips to prevent it.

Learn how therapists navigate honesty, boundaries, and transference when creative patients bring novels, paintings, or provocative images into psychotherapy.

Dissect psychodermatology with experts in both fields, from the American Academy of Dermatology 2026.

Artemis astronauts spotlight psychiatric medication, mental health support, and trust—revealing why psychiatry’s village mindset strengthens care, leadership, and ethics.

High-potency cannabis surges; psychiatry confronts psychosis risk, dependence, and data gaps—why clinicians must guide safer use now.

Faster aging may be linked to schizophrenia, according to new research.

How creativity and wisdom can grow after 80, from Matisse to modern psychiatry—boosting purpose, brain health, and connection in later life.

"While studying the CAT scan, I picture Groucho Marx..."

Bupropion may cause dose-linked tinnitus; this case shows symptoms improve after dose reduction, helping manage depression without stopping treatment.

Shared pathophysiology between Alzheimer disease and autism may expand diagnosis and treatment opportunities.

A new US-based grant program seeks to create training content for health care providers who want to be able to deliver investigational COMP360 psilocybin treatment.

Explore how sigma‑1 receptors shape ER–mitochondria signaling, calm neuroinflammation, and inspire therapies from fluvoxamine to dextromethorphan.




































